Overview

Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer

Status:
Completed
Trial end date:
2020-12-15
Target enrollment:
Participant gender:
Summary
Abraxane in patients with visceral metastases dominant metastatic breast cancer
Phase:
Phase 2
Details
Lead Sponsor:
Fudan University
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel